Table 2.
Collection period | Category | Variable | Unit(s) or categories | ||
Collected before visit of late-effects clinic | Childhood cancer type and treatment | Primary childhood cancer diagnosis | ICCC-3a classification | ||
Treatment protocol | Name and arm | ||||
Chemotherapy, per regimen | TCDb | ||||
Radiotherapy field | |||||
Cranial/craniospinal | TCD, fractions (if applicable) | ||||
Total body | TCD, fractions (if applicable) | ||||
Abdominal | TCD, fractions (if applicable) | ||||
Pancreas involvement | TCD, fractions (if applicable) | ||||
Surgery procedure | |||||
Autologous stem cell transplantation | Yes / No, conditioning regimen | ||||
Allogeneic stem cell transplantation | Yes / No, conditioning regimen | ||||
Relapse | Yes / No | ||||
Patient characteristics | Sex | Male / Female | |||
Date of birth | Date | ||||
Date of childhood cancer diagnosis | Date | ||||
Date of study measurements (follow-up date) | Date | ||||
Medical history | Height at cancer diagnosis | Centimeter | |||
Weight at cancer diagnosis | Kilogram | ||||
Growth hormone deficiency | Yes / No | ||||
Growth hormone replacement | Yes / No | ||||
Hypothyroidism | Yes / No | ||||
Hypogonadism | Yes / No | ||||
Hypocortisolism with steroid replacement | Yes / No | ||||
Collected at visit of late-effects clinic | Physical examination | Height | Centimeter | ||
Weight | Kilogram | ||||
Waist circumference | Centimeter | ||||
Hip circumference | Centimeter | ||||
Blood pressure | mmHg | ||||
General health questionnaire | Does the survivor have or has the survivor experienced | ||||
High cholesterol | Yes / No, age at diagnosis | ||||
Hypertension | Yes / No, age at diagnosis | ||||
Diabetes mellitus | Yes / No, age at diagnosis | ||||
Myocardial infarction | Yes / No, age at diagnosis | ||||
Stroke | Yes / No, age at diagnosis | ||||
Medication use | Type, dose, age at start | ||||
Smoking status | Yes / Former / No | ||||
Cardiovascular disease in family | Relative, type of disease, age at diagnosis | ||||
Questionnaire to Assess Health enhancing physical activity | N/Ac | N/A | |||
Dual-energy x-ray absorptiometry scan | Total body fat | Percentage | |||
Z-score total body fat | Z-score | ||||
Lean body mass | Kilogram per m2 | ||||
Appendicular lean body mass | Kilogram per m2 | ||||
6-minute walking test | N/A | Meter | |||
Data determined from stored samples | Serum biomarkers | ||||
High-density lipoprotein | mmol/L | ||||
Low-density lipoprotein | mmol/L | ||||
Total cholesterol | mmol/L | ||||
Apolipoprotein-B | g/L | ||||
Glucose | mmol/L | ||||
Insulin | pmol/L | ||||
Adiponectin | ug/mL | ||||
Leptin | ng/mL | ||||
Uric acid | mmol/L | ||||
High sensitivity C-reactive protein | mg/L | ||||
IL-6d | pg/mL | ||||
hsTNFae | pg/mL | ||||
IL-1f | pg/mL | ||||
IGF-1g | ug/L | ||||
Creatinine | mg/mmol | ||||
Urea | mmol/L | ||||
LHh | U/L | ||||
FSHi | U/L | ||||
AMHj | ug/L | ||||
Estradiol | pmol/L | ||||
Testosterone | nmol/L | ||||
DNA from blood/saliva | N/A |
aICCC-3: International Classification of Childhood Cancer, edition 3.
bTCD: total cumulative dose.
cN/A: not applicable.
dIL-6: interleukin-6.
ehsTNF: high-sensitivity tumor necrosis factor alpha.
fIL-1: interleukin-1.
gIGF-1: insulin-like growth factor 1.
hLH: luteinizing hormone.
iFSH: follicle stimulating hormone.
jAMH: anti-Müllerian hormone.